An annual report filed last week by Medbox, a medical marijuana dispensary caught up in a range of litigation and regulatory issues, shows that it gave two outside law firms stakes worth a total of almost $280,000 about two months before it was sold to private equity firm Lizada Capital.
Medbox, in its most recent 10-K filing with the U.S. Securities and Exchange Commission, states that between Oct. 1, 2014, and Dec. 31, 2014, it issued 46,352 shares to Manatt, Phelps & Phillips at $5.11 per share and another 6,540 shares to securities boutique Sichenzia Ross Friedman Ference at a price of $6.59 per share. The issuance of shares puts the value of Sichenzia Ross’ stake in Medbox at $43,098.60 and Manatt’s holdings at $236,858.72.
